Immunoglobulins and complement factors in senile plaques

P. Eikelenboom,F. Stam

DOI: https://doi.org/10.1007/BF00685397

IF: 15.887

1982-06-01

Acta Neuropathologica

Abstract:

What problem does this paper attempt to address?

Dosimetric calibration of anatomy‐specific ultra‐high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments

Jinghui Wang,Stavros Melemenidis,Rakesh Manjappa,Vignesh Viswanathan,Ramish M. Ashraf,Karen Levy,Lawrie B. Skinner,Luis A. Soto,Stephanie Chow,Brianna Lau,Ryan B. Ko,Edward E. Graves,Amy S. Yu,Karl K. Bush,Murat Surucu,Erinn B. Rankin,Billy W. Loo,Emil Schüler,Peter G. Maxim

DOI: https://doi.org/10.1002/mp.17432

IF: 4.506

2024-09-29

Medical Physics

Abstract:Background FLASH radiation therapy (RT) offers a promising avenue for the broadening of the therapeutic index. However, to leverage the full potential of FLASH in the clinical setting, an improved understanding of the biological principles involved is critical. This requires the availability of specialized equipment optimized for the delivery of conventional (CONV) and ultra‐high dose rate (UHDR) irradiation for preclinical studies. One method to conduct such preclinical radiobiological research involves adapting a clinical linear accelerator configured to deliver both CONV and UHDR irradiation. Purpose We characterized the dosimetric properties of a clinical linear accelerator configured to deliver ultra‐high dose rate irradiation to two anatomic sites in mice and for cell‐culture FLASH radiobiology experiments. Methods Delivered doses of UHDR electron beams were controlled by a microcontroller and relay interfaced with the respiratory gating system. We also produced beam collimators with indexed stereotactic mouse positioning devices to provide anatomically specific preclinical treatments. Treatment delivery was monitored directly with an ionization chamber, and charge measurements were correlated with radiochromic film measurements at the entry surface of the mice. The setup for conventional dose rate irradiation utilized the same collimation system but at increased source‐to‐surface distance. Monte Carlo simulations and film dosimetry were used to characterize beam properties and dose distributions. Results The mean electron beam energies before the flattening filter were 18.8 MeV (UHDR) and 17.7 MeV (CONV), with corresponding values at the mouse surface of 17.2 and 16.2 MeV. The charges measured with an external ion chamber were linearly correlated with the mouse entrance dose. The use of relay gating for pulse control initially led to a delivery failure rate of 20% (± 1 pulse); adjustments to account for the linac latency improved this rate to 95% agreement. Conclusion We successfully configured a clinical linear accelerator for increased output and developed a robust preclinical platform for anatomically specific irradiation, with highly accurate and precise temporal and spatial dose delivery, for both CONV and UHDR irradiation applications.

radiology, nuclear medicine & medical imaging
On the acceptance, commissioning, and quality assurance of electron FLASH units

Allison Palmiero,Kevin Liu,Julie Colnot,Nitish Chopra,Denae Neill,Luke Connell,Brett Velasquez,Albert C. Koong,Steven H. Lin,Peter Balter,Ramesh Tailor,Charlotte Robert,Jean‐François Germond,Patrik Gonçalves Jorge,Reiner Geyer,Sam Beddar,Raphael Moeckli,Emil Schüler

DOI: https://doi.org/10.1002/mp.17483

IF: 4.506

2024-10-29

Medical Physics

Abstract:Background and purpose FLASH or ultra‐high dose rate (UHDR) radiation therapy (RT) has gained attention in recent years for its ability to spare normal tissues relative to conventional dose rate (CDR) RT in various preclinical trials. However, clinical implementation of this promising treatment option has been limited because of the lack of availability of accelerators capable of delivering UHDR RT. Commercial options are finally reaching the market that produce electron beams with average dose rates of up to 1000 Gy/s. We established a framework for the acceptance, commissioning, and periodic quality assurance (QA) of electron FLASH units and present an example of commissioning. Methods A protocol for acceptance, commissioning, and QA of UHDR linear accelerators was established by combining and adapting standards and professional recommendations for standard linear accelerators based on the experience with UHDR at four clinical centers that use different UHDR devices. Non‐standard dosimetric beam parameters considered included pulse width, pulse repetition frequency, dose per pulse, and instantaneous dose rate, together with recommendations on how to acquire these measurements. Results The 6‐ and 9‐MeV beams of an UHDR electron device were commissioned by using this developed protocol. Measurements were acquired with a combination of ion chambers, beam current transformers (BCTs), and dose‐rate–independent passive dosimeters. The unit was calibrated according to the concept of redundant dosimetry using a reference setup. Conclusion This study provides detailed recommendations for the acceptance testing, commissioning, and routine QA of low‐energy electron UHDR linear accelerators. The proposed framework is not limited to any specific unit, making it applicable to all existing eFLASH units in the market. Through practical insights and theoretical discourse, this document establishes a benchmark for the commissioning of UHDR devices for clinical use.

radiology, nuclear medicine & medical imaging
Framework for Quality Assurance of Ultra-High Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps

Wei Zou,Rongxiao Zhang,Emil Schüler,Paige A Taylor,Anthony E Mascia,Eric S Diffenderfer,Tianyu Zhao,Ahmet S Ayan,Manju Sharma,Shu-Jung Yu,Weiguo Lu,Walter R Bosch,Christina Tsien,Murat Surucu,Julianne M Pollard-Larkin,Jan Schuemann,Eduardo G Moros,Magdalena Bazalova-Carter,David J Gladstone,Heng Li,Charles B Simone,Kristoffer Petersson,Stephen F Kry,Amit Maity,Billy W Loo,Lei Dong,Peter G Maxim,Ying Xiao,Jeffrey C Buchsbaum,Emil Schueler

DOI: https://doi.org/10.1016/j.ijrobp.2023.04.018

IF: 8.013

2023-04-01

International Journal of Radiation Oncology*Biology*Physics

Abstract:FLASH radiation therapy (FLASH-RT), delivered with ultrahigh dose rate (UHDR), may allow patients to be treated with less normal tissue toxicity for a given tumor dose compared with currently used conventional dose rate. Clinical trials are being carried out and are needed to test whether this improved therapeutic ratio can be achieved clinically. During the clinical trials, quality assurance and credentialing of equipment and participating sites, particularly pertaining to UHDR-specific aspects, will be crucial for the validity of the outcomes of such trials. This report represents an initial framework proposed by the NRG Oncology Center for Innovation in Radiation Oncology FLASH working group on quality assurance of potential UHDR clinical trials and reviews current technology gaps to overcome. An important but separate consideration is the appropriate design of trials to most effectively answer clinical and scientific questions about FLASH. This paper begins with an overview of UHDR RT delivery methods. UHDR beam delivery parameters are then covered, with a focus on electron and proton modalities. The definition and control of safe UHDR beam delivery and current and needed dosimetry technologies are reviewed and discussed. System and site credentialing for large, multi-institution trials are reviewed. Quality assurance is then discussed, and new requirements are presented for treatment system standard analysis, patient positioning, and treatment planning. The tables and figures in this paper are meant to serve as reference points as we move toward FLASH-RT clinical trial performance. Some major questions regarding FLASH-RT are discussed, and next steps in this field are proposed. FLASH-RT has potential but is associated with significant risks and complexities. We need to redefine optimization to focus not only on the dose but also on the dose rate in a manner that is robust and understandable and that can be prescribed, validated, and confirmed in real time. Robust patient safety systems and access to treatment data will be critical as FLASH-RT moves into the clinical trials.

oncology,radiology, nuclear medicine & medical imaging
Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC

Mahbubur Rahman,M. Ramish Ashraf,Rongxiao Zhang,Petr Bruza,Chad A. Dexter,Lawrence Thompson,Xu Cao,Benjamin B. Williams,P. Jack Hoopes,Brian W. Pogue,David J. Gladstone

DOI: https://doi.org/10.1016/j.ijrobp.2021.01.011

2021-02-02

Abstract:Purpose: In this study, procedures were developed to achieve efficient reversible conversion of a clinical linear accelerator (LINAC) and deliver electron FLASH (eFLASH) or conventional beams to the treatment room isocenter. Material & Methods: The LINAC was converted to deliver eFLASH beam within 20 minutes by retracting the x-ray target from the beam's path, positioning the carousel on an empty port, and selecting 10 MV photon beam energy in the treatment console. Dose per pulse and average dose rate were measured in a solid water phantom at different depths with Gafchromic film and OSLD. A pulse controller counted the pulses via scattered radiation signal and gated the delivery for preset pulse count. A fast photomultiplier tube-based Cherenkov detector measured per pulse beam output at 2 ns sampling rate. After conversion back to clinical mode, conventional beam output, flatness, symmetry, field size and energy were measured for all clinically commissioned energies. Results: Dose per pulse of 0.86 +/- 0.01 Gy (310 +/- 7 Gy/s average dose rate) were achieved at isocenter. The dose from simultaneous irradiation of film and OSLD were within 1%. The PMT showed the LINAC required about 5 pulses before the output stabilized and its long-term stability was within 3% for measurements performed at 3 minutes intervals. The dose, flatness, symmetry, and photon energy were unchanged from baseline and within tolerance (1%, 3%, 2%, and 0.1% respectively) after reverting to conventional beams. Conclusion: 10 MeV FLASH beams were achieved at the isocenter of the treatment room. The beam output was reproducible but requires further investigation of the ramp up time in the first 5 pulses, equivalent to <100 cGy. The eFLASH beam can irradiate both small and large subjects in minimally modified clinical settings and dose rates can be further increased by reducing the source to surface distance.

Medical Physics
Commissioning an ultra-high-dose-rate electron linac with end-to-end tests

Tianyuan Dai,Austin M Sloop,Muhammad R Ashraf,Jacob P Sunnerberg,Megan A Clark,Petr Bruza,Brian W Pogue,Lesley Jarvis,David J Gladstone,Rongxiao Zhang

DOI: https://doi.org/10.1088/1361-6560/ad69fc

2024-08-09

Abstract:Objective. The FLASH effect can potentially be used to improve the therapeutic ratio of radiotherapy (RT) through delivery of Ultra-high-dose-rate (UHDR) irradiation. Research is actively being conducted to translate UHDR-RT and for this purpose the Mobetron is capable of producing electron beams at both UHDR and conventional dose rates for FLASH research and translation. This work presents commissioning of an UHDR Mobetron with end-to-end tests developed for preclinical research.Approach. UHDR electron beams were commissioned with an efficient approach utilizing a 3D-printed water tank and film to fully characterize beam characteristics and dependences on field size, pulse width (PW) and pulse repetition frequency (PRF). This commissioning data was used to implement a beam model using the GAMOS Monte Carlo toolkit for the preclinical research. Then, the workflow for preclinical FLASH irradiation was validated with end-to-end tests delivered to a 3D-printed mouse phantom with internal inhomogeneities.Main results.PDDs, profiles and output factors acquired with radiochromic films were precisely measured, with a PRF that showed little effect on the UHDR beam energy and spatial characteristics. Increasing PW reduced theDmaxand R50by 2.08 mmµs-1and 1.28 mmµs-1respectively. An end-to-end test of the preclinical research workflow showed that both profiles in head-foot and lateral directions were in good agreement with the MC calculations for the heterogeneous 3D printed mouse phantom with Gamma index above 93% for 2 mm/2% criteria, and 99% for 3 mm/3%.Significance. The UHDR Mobetron is a versatile tool for FLASH preclinical research and this comprehensive beam model and workflow was validated to meet the requirements for conducting translational FLASH research.
Chemical aversion conditioning as a treatment for alcoholism: a re-analysis.

G. Wilson

DOI: https://doi.org/10.1016/0005-7967(87)90058-1

IF: 5.321

Behaviour Research and Therapy

Abstract:
Electron FLASH platform for pre-clinical research: LINAC modification, simplification of pulse control and dosimetry

Banghao Zhou,Lixiang Guo,Weiguo Lu,Mahbubur Rahman,Rongxiao Zhang,Varghese Anto Chirayath,Yang Kyun Park,Strahinja Stojadinovic,Marvin Garza,Ken Kang-Hsin Wang

2024-08-28

Abstract:Background: FLASH radiotherapy is a treatment regime that delivers therapeutic dose to tumors at an ultra-high dose rate while maintaining adequate normal tissue sparing. However, a comprehensive understanding of the underlying mechanisms, potential late toxicities, and optimal fractionation schemes is important for successful clinical translation. This has necessitated extensive pre-clinical investigations, leading several research institutions to initiate dedicated FLASH research programs. Purpose: This work describes a workflow for establishing an easily accessible electron FLASH (eFLASH) platform. The platform incorporates simplified pulse control, optimized dose rate delivery, and validated Monte Carlo (MC) dose engine for accurate in vivo dosimetry dedicated to FLASH pre-clinical studies. Methods: Adjustment of the automatic frequency control (AFC) module allowed us to optimize the LINAC pulse form to achieve a uniform dose rate. A MC model for the 6 MeV FLASH beam was commissioned to ensure accurate dose calculation necessary for reproducible in vivo studies. Results: Optimizing the AFC module enabled the generation of a uniform pulse form, ensuring consistent dose per pulse and a uniform dose rate throughout FLASH irradiation. The MC model closely agreed with film measurements. MC dose calculations indicated that 6 MeV FLASH is adequate to achieve a uniform dose distribution for mouse whole brain irradiation but may not be optimal for the spinal cord study. Conclusions: We present a novel workflow for establishing a LINAC-based eFLASH research platform, incorporating techniques for optimized dose rate delivery, a simplified pulse control system, and validated MC engine. This work provides researchers with valuable new approaches to facilitate the development of robust and accessible LINAC-based system for FLASH studies.

Medical Physics
Dosimetric calibration of an anatomically specific ultra-high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments

Jinghui Wang,Stavros Melemenidis,Rakesh Manjappa,Vignesh Viswanathan,Ramish M. Ashraf,Karen Levy,Lawrie Skinner,Luis A. Soto,Stephanie Chow,Brianna Lau,Ryan B. Ko,Edward E. Graves,Amy S. Yu,Karl K. Bush,Murat Surucu,Erinn B. Rankin,Billy W. Loo Jr,Emil Schüler,Peter G. Maxim

2023-12-17

Abstract:We characterized the dosimetric properties of a clinical linear accelerator configured to deliver ultra-high dose rate (UHDR) irradiation to mice and cell-culture FLASH radiobiology experiments. UHDR electron beams were controlled by a microcontroller and relay interfaced with the respiratory gating system. We produced beam collimators with indexed stereotactic mouse positioning devices to provide anatomically specific preclinical treatments. Treatment delivery was monitored directly with an ionization chamber, and charge measurements were correlated with radiochromic film at the entry surface of the mice. The setup for conventional (CONV) dose rate irradiation was similar but the source-to-surface distance was longer. Monte Carlo simulations and film dosimetry were used to characterize beam properties and dose distributions. The mean electron beam energies before the flattening filter were 18.8 MeV (UHDR) and 17.7 MeV (CONV), with corresponding values at the mouse surface of 17.2 MeV and 16.2 MeV. The charges measured with an external ion chamber were linearly correlated with the mouse entrance dose. Use of relay gating for pulse control initially led to a delivery failure rate of 20% ($+/-$ 1 pulse); adjustments to account for the linac latency improved this rate to <1/20. Beam field sizes for two anatomically specific mouse collimators (4x4 $cm^2$ for whole-abdomen and 1.5x1.5 $cm^2$ for unilateral lung irradiation) were accurate within <5% and had low radiation leakage (<4%). Normalizing the dose at the center of the mouse (~0.75 cm depth) produced UHDR and CONV doses to the irradiated volumes with >95% agreement. We successfully configured a clinical linear accelerator for increased output and developed a robust preclinical platform for anatomically specific irradiation, with highly accurate and precise temporal and spatial dose delivery, for both CONV and UHDR applications.

Medical Physics
Ultrahigh dose-rate (FLASH) x-ray irradiator for pre-clinical laboratory research

Mohammad Rezaee,Iulian Iordachita,John W Wong

DOI: https://doi.org/10.1088/1361-6560/abf2fa

IF: 3.5

2021-04-23

Physics in Medicine and Biology

Abstract:Abstract FLASH irradiation has been shown to reduce significantly normal tissue toxicity compared to conventional irradiation, while maintaining tumor control probability at similar level. Clinical translation of FLASH irradiation necessitates comprehensive laboratory studies to elucidate biological effects as well as pertinent technological and physical requirements. At present, FLASH research employs complex accelerator technologies of limited accessibilities. Here, we study the feasibility of a novel self-shielded x-ray irradiation cabinet system, as an enabling technology to enhance the preclinical research capabilities. The proposed system employs two commercially available high capacity 150 kVp fluoroscopy x-ray sources with rotating anode technology in a parallel-opposed arrangement. Simulation was performed with the GEANT4 Monte-Carlo platform. Simulated dosimetric properties of the x-ray beam for both FLASH and conventional dose-rate irradiations were characterized. Dose and dose rate from a single kV x-ray fluoroscopy source in solid water phantom were verified with measurements using Gafchromic films. The parallel-opposed x-ray sources can deliver over 50 Gy doses to a 20 mm thick water equivalent medium at ultrahigh dose-rates of 40–240 Gy s −1 . A uniform depth-dose rate (±5%) is achieved over 8–12 mm in the central region of the phantom. Mirrored beams minimize heel effect of the source and achieve reasonable cross-beam uniformity (±3%). Conventional dose-rate irradiation (≤0.1 Gy s −1 ) can also be achieved by reducing the tube current and increasing the distance between the phantom and tubes. The rotating anode x-ray source can be used to deliver both FLASH and conventional dose-rate irradiations with the field dimensions well suitable for small animal and cell-culture irradiations. For FLASH irradiation using parallel-opposed sources, entrance and exit doses can be higher by 30% than the dose at the phantom center. Beam angling can be employed to minimize the high surface doses. Our proposed system is amendable to self-shielding and enhance research in regular laboratory setting.

engineering, biomedical,radiology, nuclear medicine & medical imaging
Towards clinical application of ultra-high dose rate radiotherapy and the FLASH effect: Challenges and current status

Abdulhamid Chaikh,Magali Édouard,Christelle Huet,Fabien Milliat,Carmen Villagrasa,Aurélie Isambert

DOI: https://doi.org/10.1016/j.canrad.2024.07.001

Abstract:Ultra-high dose rate external beam radiotherapy (UHDR-RT) uses dose rates of several tens to thousands of Gy/s, compared with the dose rate of the order of a few Gy/min for conventional radiotherapy techniques, currently used in clinical practice. The use of such dose rate is likely to improve the therapeutic index by obtaining a radiobiological effect, known as the "FLASH" effect. This would maintain tumor control while enhancing tissues protection. To date, this effect has been achieved using beams of electrons, photons, protons, and heavy ions. However, the conditions required to achieve this "FLASH" effect are not well defined, and raise several questions, particularly with regard to the definition of the prescription, including dose fractionation, irradiated volume and the temporal structure of the pulsed beam. In addition, the dose delivered over a very short period induces technical challenges, particularly in terms of detectors, which must be mastered to guarantee safe clinical implementation. IRSN has carried out an in-depth literature review of the UHDR-RT technique, covering various aspects relating to patient radiation protection: the radiobiological mechanisms associated with the FLASH effect, the used temporal structure of the UHDR beams, accelerators and dose control, the properties of detectors to be used with UHDR beams, planning, clinical implementation, and clinical studies already carried out or in progress.
[Effect of pressure on palatal soft tissue: histological study].

M. Ai

1980-12-01

Abstract:
[Mass spectral analysis of water in intact dental enamel in subjects with different caries resistance].

V. B. Nedoseko,I. Gorbunova,V. Drozdov

Abstract:Mass-spectrum analysis of specimens of intact dental enamel of subjects with different caries resistance was carried out. Products of gaseous phase released during constant heating of enamel were analyzed. Water mass spectrum was distinguished to be used in thermal programmed desorption analysis for the study of the organic constituent of dental enamel.
Technical note: A small animal irradiation platform for investigating the dependence of the FLASH effect on electron beam parameters

Kevin E. Byrne,Yannick Poirier,Junliang Xu,Andrew Gerry,Mark J. Foley,Isabel Lauren Jackson,Amit Sawant,Kai Jiang

DOI: https://doi.org/10.1002/mp.16909

IF: 4.506

2024-01-13

Medical Physics

Abstract:Background The recent rediscovery of the FLASH effect, a normal tissue sparing phenomenon observed in ultra‐high dose rate (UHDR) irradiations, has instigated a surge of research endeavors aiming to close the gap between experimental observation and clinical treatment. However, the dependences of the FLASH effect and its underpinning mechanisms on beam parameters are not well known, and large‐scale in vivo studies using murine models of human cancer are needed for these investigations. Purpose To commission a high‐throughput, variable dose rate platform providing uniform electron fields (≥15 cm diameter) at conventional (CONV) and UHDRs for in vivo investigations of the FLASH effect and its dependences on pulsed electron beam parameters. Methods A murine whole‐thoracic lung irradiation (WTLI) platform was constructed using a 1.3 cm thick Cerrobend collimator forming a 15 × 1.6 cm2 slit. Control of dose and dose rate were realized by adjusting the number of monitor units and couch vertical position, respectively. Achievable doses and dose rates were investigated using Gafchromic EBT‐XD film at 1 cm depth in solid water and lung‐density phantoms. Percent depth dose (PDD) and dose profiles at CONV and various UHDRs were also measured at depths from 0 to 2 cm. A radiation survey was performed to assess radioactivation of the Cerrobend collimator by the UHDR electron beam in comparison to a precision‐machined copper alternative. Results This platform allows for the simultaneous thoracic irradiation of at least three mice. A linear relationship between dose and number of monitor units at a given UHDR was established to guide the selection of dose, and an inverse‐square relationship between dose rate and source distance was established to guide the selection of dose rate between 20 and 120 Gy·s−1. At depths of 0.5 to 1.5 cm, the depth range relevant to murine lung irradiation, measured PDDs varied within ±1.5%. Similar lateral dose profiles were observed at CONV and UHDRs with the dose penumbrae widening from 0.3 mm at 0 cm depth to 5.1 mm at 2.0 cm. The presence of lung‐density plastic slabs had minimal effect on dose distributions as compared to measurements made with only solid water slabs. Instantaneous dose rate measurements of the activated copper collimator were up to two orders of magnitude higher than that of the Cerrobend collimator. Conclusions A high‐throughput, variable dose rate platform has been developed and commissioned for murine WTLI electron FLASH radiotherapy. The wide field of our UHDR‐enabled linac allows for the simultaneous WTLI of at least three mice, and for the average dose rate to be modified by changing the source distance, without affecting dose distribution. The platform exhibits uniform, and comparable dose distributions at CONV and UHDRs up to 120 Gy·s−1, owing to matched and flattened 16 MeV CONV and UHDR electron beams. Considering radioactivation and exposure to staff, Cerrobend collimators are recommended above copper alternatives for electron FLASH research. This platform enables high‐throughput animal irradiation, which is preferred for experiments using a large number of animals, which are required to effectively determine UHDR treatment efficacies.

radiology, nuclear medicine & medical imaging
FLASH: New intersection of physics, chemistry, biology, and cancer medicine

Marie-Catherine Vozenin,Billy W. Loo,Sami Tantawi,Peter G. Maxim,Douglas R. Spitz,Claude Bailat,Charles L. Limoli

DOI: https://doi.org/10.1103/revmodphys.96.035002

IF: 50.485

2024-09-21

Reviews of Modern Physics

Abstract:Ultrahigh dose rate, FLASH radiotherapy has emerged as one of the most promising innovations over the past decade in the field of radiation oncology, with the potential to eradicate radiation resistant primary tumors and improve the therapeutic outcome for cancer patients. FLASH is based on delivering radiation doses at ultrahigh dose rates (UHDR; >40 Gy/s ), more than 1000 times faster than irradiation at conventional dose rates (CONV). The experimental evidence demonstrating the differential effect of dose rate modulation on tumors and normal tissue is reviewed. Preclinical data consistently show that the antitumor efficacy of cytotoxic doses is not dependent on dose rate, but in normal tissues UHDR significantly reduces normal tissue toxicities compared to CONV, as observed in vivo . These observations define the FLASH effect. The FLASH effect has been reported to occur when using single or hypofractionated dose regimens in several experimental animal models (mice, rat, zebrafish, pig, and cats) and in multiple organs (lung, skin, gut, and brain) by numerous groups worldwide. Note that the FLASH effect has been demonstrated with electron, photon, and hadron (proton and heavier ion) beams. The current status and future technological development are reviewed, with an emphasis on critical beam parameters, future beam modalities, and prerequisites for safe clinical translation in terms of dosimetry, radioprotection, and treatment planning systems. Mechanistic investigations at the physicochemical and biological levels are presented, as are strategies to support and initiate clinical translation. This comprehensive review provides multidisciplinary radiation scientists with a road map of the technological, physical, chemical, biological, and clinical considerations that have made FLASH topical. These considerations are presented with a realistic and practical backdrop of the limitations and challenges that lie ahead. https://doi.org/10.1103/RevModPhys.96.035002 © 2024 American Physical Society

physics, multidisciplinary
Failure of Parathormone to Affect Insulin and Glucagon Release from the Perfused Rat Pancreas

O. Rebolledo,V. Leclercq-Meyer,J. Marchand,R. Leclercq,W. Malaisse

DOI: https://doi.org/10.1055/s-0028-1093756

1975-07-01

Abstract:Parathormone (0.15 U/ml) failed to affect the rate of glucagon and insulin release by the perfused rat pancreas exposed to glucose in either low (3.3 mM) or high (8.3 mM) concentration. Parathormone also failed to interfere with the suppressive effect of glucose (16.6mM) upon glucagon release and its stimulatory action upon insulin secretion. Likewise, the biphasic release of both glucagon and insulin evoked by arginine (10.0 mM) in the presence of glucose (8.3 mM) was unaffected by parathormone. These findings suggest that the endocrine pancreas may not be a target organ for any direct and immediate action of parathormone.
Beam control system and output fine-tuning for safe and precise delivery of FLASH radiotherapy at a clinical linear accelerator

Elise Konradsson,Pontus Wahlqvist,Andreas Thoft,Börje Blad,Sven Bäck,Crister Ceberg,Kristoffer Petersson

DOI: https://doi.org/10.3389/fonc.2024.1342488

IF: 4.7

2024-01-19

Frontiers in Oncology

Abstract:Introduction: We have previously adapted a clinical linear accelerator (Elekta Precise, Elekta AB) for ultra-high dose rate (UHDR) electron delivery. To enhance reliability in future clinical FLASH radiotherapy trials, the aim of this study was to introduce and evaluate an upgraded beam control system and beam tuning process for safe and precise UHDR delivery. Materials and Methods: The beam control system is designed to interrupt the beam based on 1) a preset number of monitor units (MUs) measured by a monitor detector, 2) a preset number of pulses measured by a pulse-counting diode, or 3) a preset delivery time. For UHDR delivery, an optocoupler facilitates external control of the accelerator's thyratron trigger pulses. A beam tuning process was established to maximize the output. We assessed the stability of the delivery, and the independent interruption capabilities of the three systems (monitor detector, pulse counter, and timer). Additionally, we explored a novel approach to enhance dosimetric precision in the delivery by synchronizing the trigger pulse with the charging cycle of the pulse forming network (PFN). Results: Improved beam tuning of gun current and magnetron frequency resulted in average dose rates at the dose maximum at isocenter distance of >160 Gy/s or >200 Gy/s, with or without an external monitor chamber in the beam path, respectively. The delivery showed a good repeatability (standard deviation (SD) in total film dose of 2.2%) and reproducibility (SD in film dose of 2.6%). The estimated variation in DPP resulted in an SD of 1.7%. The output in the initial pulse depended on the PFN delay time. Over the course of 50 measurements employing PFN synchronization, the absolute percentage error between the delivered number of MUs calculated by the monitor detector and the preset MUs was 0.8 ± 0.6% (mean ± SD). Conclusion: We present an upgraded beam control system and beam tuning process for safe and stable UHDR electron delivery of hundreds of Gy/s at isocenter distance at a clinical linac. The system can interrupt the beam based on monitor units and utilize PFN synchronization for improved dosimetric precision in the dose delivery, representing an important advancement toward reliable clinical FLASH trials.

oncology
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy – An evaluation of dosimetric performances

Till Tobias Böhlen,Jean-François Germond,Laurent Desorgher,Izabella Veres,Andreas Bratel,Eric Landström,Erik Engwall,Fernanda G Herrera,Esat Mahmut Ozsahin,Jean Bourhis,François Bochud,Raphaël Moeckli,Jean‐François Germond,Fernanda G. Herrera

DOI: https://doi.org/10.1016/j.radonc.2024.110177

IF: 6.901

2024-02-20

Radiotherapy and Oncology

Abstract:Purpose Clinical translation of FLASH-radiotherapy (RT) to deep-seated tumours is still a technological challenge. One solution consists of using ultra-high dose rate transmission proton (TP) beams of about 200-250MeV to irradiate the tumour with the flat entrance of the proton depth-dose profile. This work evaluates the dosimetric performance of very high-energy electron (VHEE)-based RT (50-250MeV) as a potential alternative to TP-based RT for the clinical transfer of the FLASH effect. Methods Basic physics characteristics of VHEE and TP beams were compared utilizing Monte Carlo simulations in water. A VHEE-enabled research treatment planning system was used to evaluate the plan quality achievable with VHEE beams of different energies, compared to 250MeV TP beams for a glioblastoma, an oesophagus, and a prostate cancer case. Results Like TP, VHEE above 100MeV can treat targets with roughly flat (within ±20%) depth-dose distributions. The achievable dosimetric target conformity and adjacent organs-at-risk (OAR) sparing is consequently driven for both modalities by their lateral beam penumbrae. 10cm-diameter electron beams of 400[500] MeV match the penumbra of 200[250] MeV TP beams and penumbra is increased for lower electron energies. For the investigated patient cases, VHEE plans with energies of 150MeV and above achieved a dosimetric plan quality comparable to that of 250MeV TP plans. For the glioblastoma and the oesophagus case, although having a decreased conformity, even 100MeV VHEE plans provided a similar target coverage and OAR sparing compared to TP. Conclusions VHEE-based FLASH-RT using sufficiently high beam energies may provide a lighter-particle alternative to TP-based FLASH-RT with comparable dosimetric plan quality.

oncology,radiology, nuclear medicine & medical imaging
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic

Billy W Loo Jr,Ioannis I Verginadis,Brita Singers Sørensen,Anthony E Mascia,John P Perentesis,Albert C Koong,Emil Schüler,Erinn B Rankin,Peter G Maxim,Charles L Limoli,Marie-Catherine Vozenin

DOI: https://doi.org/10.1016/j.semradonc.2024.04.008

Abstract:The "FLASH effect" is an increased therapeutic index, that is, reduced normal tissue toxicity for a given degree of anti-cancer efficacy, produced by ultra-rapid irradiation delivered on time scales orders of magnitude shorter than currently conventional in the clinic for the same doses. This phenomenon has been observed in numerous preclinical in vivo tumor and normal tissue models. While the underlying biological mechanism(s) remain to be elucidated, a path to clinical implementation of FLASH can be paved by addressing several critical translational questions. Technological questions pertinent to each beam type (eg, electron, proton, photon) also dictate the logical progression of experimentation required to move forward in safe and decisive clinical trials. Here we review the available preclinical data pertaining to these questions and how they may inform strategies for FLASH cancer therapy clinical trials.
Characterization of a modified clinical linear accelerator for ultra-high dose rate electron beam delivery

Umberto Deut,Aurora Camperi,Cristiano Cavicchi,Roberto Cirio,Emanuele Data,Elisabetta Durisi,Veronica Ferrero,Arianna Ferro,Simona Giordanengo,Oscar A. Martì Villarreal,Felix Mas Milian,Elisabetta Medina,Diango M. Montalvan Olivares,Franco Mostardi,Valeria Monti,Roberto Sacchi,Edoardo Salmeri,Anna Vignati

2024-07-23

Abstract:Irradiations at Ultra High Dose Rate (UHDR) regimes, exceeding 40 Gy/s in single fractions lasting less than 200 ms, have shown an equivalent antitumor effect compared to conventional radio-therapy with reduced harm to normal tissues. This work details the hardware and software modi-fications implemented to deliver 10 MeV UHDR electron beams with a Linear Accelerator Elekta SL 18 MV and the beam characteristics obtained. GafChromic EBT XD films and an Advanced Markus chamber were used for the dosimetry characterization, while a silicon sensor assessed the machine's beam pulses stability and repeatability. Dose per pulse, average dose rate and instantaneous dose rate in the pulse were evaluated for four experimental settings, varying the source-to-surface dis-tance and the beam collimation, i.e. with and without the use of a cylindrical applicator. Results showed dose per pulse from 0.6 Gy to a few tens of Gy and average dose rate up to 300 Gy/s. The obtained results demonstrate the possibility to perform in-vitro radiobiology experiments and test of new technologies for beam monitoring and dosimetry at the upgraded LINAC, thus contributing to the electron UHDR research field.

Medical Physics

Immunoglobulins and complement factors in senile plaques

Dosimetric calibration of anatomy‐specific ultra‐high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments

On the acceptance, commissioning, and quality assurance of electron FLASH units

Framework for Quality Assurance of Ultra-High Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps

Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC

Commissioning an ultra-high-dose-rate electron linac with end-to-end tests

Chemical aversion conditioning as a treatment for alcoholism: a re-analysis.

Electron FLASH platform for pre-clinical research: LINAC modification, simplification of pulse control and dosimetry

Dosimetric calibration of an anatomically specific ultra-high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments

Ultrahigh dose-rate (FLASH) x-ray irradiator for pre-clinical laboratory research

Towards clinical application of ultra-high dose rate radiotherapy and the FLASH effect: Challenges and current status

[Effect of pressure on palatal soft tissue: histological study].

[Mass spectral analysis of water in intact dental enamel in subjects with different caries resistance].

Technical note: A small animal irradiation platform for investigating the dependence of the FLASH effect on electron beam parameters

FLASH: New intersection of physics, chemistry, biology, and cancer medicine

Failure of Parathormone to Affect Insulin and Glucagon Release from the Perfused Rat Pancreas

Beam control system and output fine-tuning for safe and precise delivery of FLASH radiotherapy at a clinical linear accelerator

Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy – An evaluation of dosimetric performances

Navigating the Critical Translational Questions for Implementing FLASH in the Clinic

Characterization of a modified clinical linear accelerator for ultra-high dose rate electron beam delivery